An interventional study of QoLibri Digital Therapy in Chronic Pain, sponsored by Novesia. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-04.
Sponsored by Novesia · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 135 studies in Chronic Pain with a site in France — 35 open to participants now, 39 under way, 2 of them phase 3. Chronic Pain · France.
Among the 135 studies in Chronic Pain with a site in France, this one is the 7th largest by planned enrollment of the 67 interventional ones that give a count, is one of 8 that started in 2025, is one of 44 with no phase, reaches primary completion later than 13 of the 38 other live ones, and was the 117th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →35 of the 135 studies in Chronic Pain with a site in France are open now. Recruiting first, the newest first:
Nantes University Hospital · Sites in France
Ages 18+
Institut Rafael · Sites in France
Ages 18+
Hospital Ambroise Paré Paris · Sites in France
Ages 18–80
Centre Medical ISM (Integrative Systemic Medicine) · Sites in France
Ages 18+
Medtronic · Sites in France, United States, Belgium and 1 more country
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
135 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 7 · Phase 3 13 · Phase 4 3
First in 2003; this study’s year is marked. 8 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 410 is above the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 78 across the 67 interventional studies, 160 across the 68 observational. Of the 84 that completed or were terminated, 11 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
21 of 135 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Novesia as lead sponsor.
Novesia has 1 study filed under Chronic Pain — fewer than ten, so there is no comparison to draw.
14 of the studies in Chronic Pain with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06964243Institut pour la Pratique et l'Innovation en PSYchologie appliquée (Institut Pi-Psy)Protocol Assessment of Motor Cortex rTMS for Treating Neuropathic Pain | 2026-12-19 |
| NCT07877376Nadine ATTALImpact of Cognitive Impairment on Chronic Pain in Breast Cancer | 2027-01 |
| NCT06811077Fondation Hôpital Saint-JosephEvaluation of Individual Health Coaching Sessions Provided by a Patient Expert As Part of Therapeutic Education for Patients Registered At the Chronic Pain Consultation | 2027-01-15 |
| NCT07280338University Hospital, BrestEmotional Intelligence and Chronic Orofacial Pain | 2027-02-09 |
| NCT06841276NovesiaImpact of QoLibri Medical Device on the Consequences of Chronic Pain: a Randomized Controlled Trial | 2027-03 |
Add all 14 to your calendar (.ics) → With an account.
Among the 135 studies in Chronic Pain with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A superiority study evaluating the impact of the QoLibri Software as Medical Device on functional and psychological consequences of chronic pain in primary care patients. A prospective, cluster-randomized, wait list, controlled multicentre study with the main objective of evaluating the effectiveness of the QoLibri Digital Therapy on Quality of Life improvement in patients living with chronic pain.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Use of the QoLibri Digital Therapy on patient smartphone (on top of Treatment as Usual) for the 6-month experimental phase of the study
Device: QoLibri Digital Therapy
Treatment as Usual for the initial 3-month experimental phase (wait list) and then Use of the QoLibri Digital Therapy on patient smartphone for the remaining 3-month experimental phase of the study
A personalized program intended for chronic pain patients. It includes digitalized physical and psychological complementary approaches dedicated to symptoms management and quality of life improvement.
Effectiveness of QoLibri Digital Therapy
Pain repercussions measured through the Pain Impact Score (PIS) which combines scores from 3 different domains evaluated by the PROMIS-29 (pain intensity, physical function, and pain interference) and quantifies the extent to which pain interferes with function and daily activities).
Time frame: month 3
Reduction of pain repercussions
Reduction of pain repercussions measured through the Pain Impact Score (PIS)
Time frame: day 0, month 3, month 6
Impact on Psychological Health
Improvement in Mental Quality of Life measured by the MHS score
Time frame: day 0, month 3, month 6
Impact on Physical Health
Improvement in Physical Quality of Life measured by the PHS score
Time frame: day 0, month 3, month 6
Overall Quality of Life
Improvement in overall Quality of Life measured by the PROMIS-29 domain scores
Time frame: day 0, month 3, month 6
Global Impression of Change
Evaluation of patient and clinician global impression of change measured by P-GIC and C-GIC
Time frame: month 3, month 6
Organizational impact
Evaluation of care organization measured by an in-house questionnaire
Time frame: day 0, month 3, month 6
Evaluation of the perceived user experience
Perceived user experience of the patient and the clinician measured by an in-house questionnaire
Time frame: month 3, month 6
Evaluation of the perceived severity of pain
Perceived severity of the pain measured by the Categorical Pain Scale
Time frame: day 0, month 3, month 6
Plan to share: Undecided
No publications or documents are linked to this record.
Started Feb 2025 (actual). Primary completion is estimated for Mar 2027, 25 months after the start.
Of 83 industry-sponsored interventional studies with no phase under Chronic Pain, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 30. This study's planned 25 months is above that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.